借款展期
Search documents
北京阳光诺和药物研究股份有限公司 关于股票回购增持借款展期的公告
Zhong Guo Zheng Quan Bao - Zhong Zheng Wang· 2026-01-05 16:51
证券代码:688621 证券简称:阳光诺和 公告编号:2026-001 北京阳光诺和药物研究股份有限公司 二、股份回购实施结果 公司于2025年3月6日披露了《关于股份回购实施结果暨股份变动的公告》(公告编号:2025-013),公 司累计回购股份272.1783万股,占总股本的比例为2.43%,支付的资金总额为99,968,608.46元(不含印 花税、交易佣金等交易费用)。 三、借款合同展期情况 近日,公司与中国邮政储蓄银行股份有限公司北京昌平区支行签署了《公司信贷业务合同补充协议》, 原借款合同约定的借款期限由12个月延长至24个月,借款用途不变。 特此公告。 关于股票回购增持借款展期的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏,并对其内容 的真实性、准确性和完整性依法承担法律责任。 一、公司回购股份的基本情况 北京阳光诺和药物研究股份有限公司(以下简称"公司")于2024年12月26日在上海证券交易所网站 (www.sse.com.cn)披露了《关于以集中竞价交易方式回购公司股份方案的公告》(公告编号:2024- 057),公司拟通过集中竞价交易方式回购公司已 ...
云南城投置业股份有限公司关于公司向下属参股公司提供借款展期的进展公告
Zhong Guo Zheng Quan Bao - Zhong Zheng Wang· 2026-01-05 16:49
本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏,并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示: ● 云南城投置业股份有限公司(下称"公司")对云南澄江老鹰地旅游度假村有限公司(下称"老鹰地公 司")、大理满江康旅投资有限公司(下称"大理满江")、云南华侨城实业有限公司(下称"华侨城实 业")的存量借款于2025年12月31日到期。为支持上述三家参股公司开展业务,满足资金周转及日常经 营,公司拟对前期已向上述三家参股公司提供的借款本金余额共计18,535.02万元及利息进行展期,展期 至2026年12月31日。2025年12月31日,公司与上述三家参股公司分别签署借款展期协议。 ● 本次借款展期的相关事宜已由公司2025年第七次临时股东会授权公司总经理办公会进行决策,无需提 交董事会、股东会审议。 一、本次借款展期事项概述 为支持公司下属参股公司老鹰地公司、大理满江以及华侨城实业的项目开发建设,公司对三家参股公司 提供了股东借款,具体情况如下: 公司于2017年向老鹰地公司提供股东借款,老鹰地公司陆续归还了部分借款;期间,双方就借款展期事 宜进行协商,并根据历 ...
潍坊亚星化学股份有限公司 第九届董事会第二十次会议决议公告
Zhong Guo Zheng Quan Bao - Zhong Zheng Wang· 2025-12-25 01:14
登录新浪财经APP 搜索【信披】查看更多考评等级 股票代码:600319 股票简称:亚星化学 编号:临2025-059 潍坊亚星化学股份有限公司 第九届董事会第二十次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏,并对其内容 的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况 潍坊亚星化学股份有限公司(以下简称"公司")于2025年12月19日发出关于召开第九届董事会第二十次 会议的通知,于2025年12月23日以通信的会议方式召开第九届董事会第二十次会议。本次会议应出席的 董事9名,实际出席的董事9名。会议由董事长韩海滨先生主持,会议的召开和表决程序符合《中华人民 共和国公司法》和《潍坊亚星化学股份有限公司章程》的有关规定。 二、董事会会议审议情况 本次董事会会议审议并通过了如下议案: (一)审议通过《关于变更会计师事务所的议案》 本议案在董事会审议前已经公司董事会审计委员会审议通过。 本议案尚需提交公司股东会审议。 具体内容请查阅同日披露于上海证券交易所网站(www.sse.com.cn)的《关于变更会计师事务所的公 告》(公告编号:临2025-0 ...
北京空港科技园区股份有限公司关于为全资子公司提供担保的公告
Shang Hai Zheng Quan Bao· 2025-12-15 19:17
关于为全资子公司提供担保的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏,并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示: ● 担保对象及基本情况 一、担保情况概述 (一)担保的基本情况 公司全资子公司天地物业为满足自身经营发展的资金需求,向中国银行股份有限公司北京自贸试验区临 空经济核心区支行(以下简称"中国银行")申请综合授信,额度上限为1,000万元,授信期限为1年,利 率不超过2.5%,具体授信额度及利率以银行最终审批为准。本次天地物业申请综合授信需由公司为其 提供连带责任保证担保,担保额度为主债权本金1,000万元及其所产生的其他费用(包括利息、复利、 罚息、违约金、损害赔偿金和实现债权的费用。实现债权的费用包括但不限于催收费用、诉讼费或仲裁 费、保全费、公告费、执行费、律师费、差旅费及其它费用) 登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码:600463 证券简称:空港股份 公告编号:临2025-088 北京空港科技园区股份有限公司 (二)内部决策程序 公司第八届董事会第十三次会议以七票赞成、零票反对、零票弃权的表决结果审议通过 ...
江苏吴中医药发展股份有限公司关于公司及子公司向银行申请借款展期的公告
Shang Hai Zheng Quan Bao· 2025-12-14 20:40
目前,基于公司整体生产经营考虑,公司及子公司医药集团向浙商银行股份有限公司苏州分行申请上述 银行贷款展期业务,具体展期时间如下: 一、本次向银行申请借款展期的情况概述 2025年度,江苏吴中医药发展股份有限公司(以下简称"公司")及子公司江苏吴中医药集团有限公司 (以下简称"医药集团")与浙商银行股份有限公司苏州分行签订多笔借款合同,具体如下: ■ ■ 注:上表中医药集团与浙商银行股份有限公司苏州分行的借款由公司作为保证人,该担保事项已由公司 第十一届董事会第四次会议和2024年年度股东大会审议通过。该笔借款展期(即2026年2月11日至2027 年2月11日)后仍由公司作为保证人,公司届时将召开董事会和股东大会审议相关事项。 二、本次贷款展期对公司经营的影响 证券代码:600200 证券简称:退市苏吴 公告编号:临2025-145 江苏吴中医药发展股份有限公司关于公司及子公司向银行申请借款展期的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏,并对其内容 的真实性、准确性和完整性承担法律责任。 2025年12月15日 本次银行借款展期事项是公司结合实际经营情况和现金流状况 ...
康佳集团股份有限公司 第十一届董事会第三次会议决议公告
Zhong Guo Zheng Quan Bao - Zhong Zheng Wang· 2025-09-11 22:40
Group 1 - The company held its 11th Board of Directors' third meeting on September 11, 2025, with all 9 directors present, discussing various proposals [2][3][31] - The board approved a proposal to extend loans provided by Chongqing Konka Optoelectronics Technology Co., Ltd. to its shareholders, with a maximum extension amount of 100 million yuan, due by October 31, 2026 [3][14][21] - The board also approved the appointment of Xinyong Zhonghe Accounting Firm as the financial statement auditor and internal control auditor for the year 2025 [6][30][31] Group 2 - The company plans to hold the 5th extraordinary shareholders' meeting on September 29, 2025, to discuss the loan extension proposal and other matters [10][46][49] - The meeting will allow both on-site and online voting, with specific timeframes for each voting method [51][62] - Shareholders must register by September 29, 2025, to participate in the meeting [59][60]
新筑股份: 关于召开2025年第五次临时股东大会的通知公告
Zheng Quan Zhi Xing· 2025-07-09 11:13
Meeting Overview - The company will hold its fifth extraordinary general meeting of shareholders in 2025 on July 25, 2025 [1] - The meeting will be convened by the board of directors and has been approved in a prior board meeting [1] - The meeting will be conducted both in-person and via online voting [1] Voting Details - Shareholders registered by the cutoff date of July 18, 2025, are eligible to attend and vote [1] - Voting will take place from 9:15 AM to 3:00 PM on the day of the meeting [1] - Specific procedures for registration and voting are outlined, including requirements for both corporate and individual shareholders [3][6] Agenda Items - The main proposal for discussion is regarding the extension of a loan from Sichuan Development (Holding) Co., Ltd., which is classified as a related party transaction [2] - The proposal has been previously reviewed and approved by the board [2] Registration and Participation - Detailed registration methods for both corporate and individual shareholders are provided, including necessary documentation [3] - Shareholders can also register via fax if they are unable to attend in person [3] Additional Information - The meeting will include provisions for separate voting for minority investors and related party shareholders [2][3] - The company has made arrangements for online voting through the Shenzhen Stock Exchange's systems [6]
惠城环保: 第三届监事会第三十五次会议决议的公告
Zheng Quan Zhi Xing· 2025-06-29 16:17
Group 1 - The company held its 35th meeting of the third supervisory board on June 27, 2025, with all three supervisors present, and the meeting was conducted in accordance with relevant laws and regulations [1][5][10] - The company has adjusted the project name, implementation entity, and location for one of the fundraising projects, "Comprehensive Utilization of Petroleum Coke Hydrogen Ash Residue Project (Phase II)," while the total investment and fundraising amounts remain unchanged [1][5][10] - The total amount of funds to be raised through the issuance of shares to specific targets is not to exceed 850 million yuan, with net proceeds intended for specific projects [1][5][10] Group 2 - The company can adjust the order and specific amounts of investment in the fundraising projects based on actual project progress and funding needs, and may use self-raised funds prior to the arrival of the raised funds [5][10] - The company plans to extend a loan of no more than 130 million yuan to its subsidiary, Guangdong Dongyue Environmental Technology Co., Ltd., with the loan term extended to June 27, 2028, to support its business development [10] - The resolutions made during the supervisory board meeting were unanimously approved, with no votes against or abstentions [1][5][10]
惠城环保: 中德证券有限责任公司关于青岛惠城环保科技集团股份有限公司向控股子公司提供借款展期的核查意见
Zheng Quan Zhi Xing· 2025-06-29 16:06
Summary of Key Points Core Viewpoint - The company Qingdao Huicheng Environmental Protection Technology Group Co., Ltd. plans to extend a loan to its controlling subsidiary, Guangdong Dongyue Environmental Technology Co., Ltd., to support its daily operations and alleviate financial pressure, with a loan amount not exceeding 130 million RMB and a term extension of up to 12 months [1][2][9]. Loan Provision Overview - The loan provision was approved in the third board meeting and the third supervisory board meeting held on June 27, 2024, allowing for a maximum loan of 130 million RMB to Dongyue Environmental, with a loan term not exceeding 12 months and an interest rate not lower than the benchmark lending rate published by the People's Bank of China [1][2]. Loan Extension Rationale - The extension is based on the recognition of Dongyue Environmental's technical strength and future development potential, aimed at further supporting its daily operations and business development [2]. Company and Subsidiary Information - Dongyue Environmental is a limited liability company with a registered capital of 246.76 million RMB, established on December 18, 2020, and is involved in various environmental protection services and equipment manufacturing [2][5]. Shareholding Structure - As of the date of the report, Huicheng Environmental holds 93.21% of Dongyue Environmental, indicating substantial control over the subsidiary [4][7]. Financial Performance - As of March 2025, Dongyue Environmental reported total assets of 176.15 million RMB, total liabilities of 122.82 million RMB, and net assets of 53.33 million RMB, with a net profit of 1.86 million RMB for the first quarter [5][6]. Decision-Making Process - The loan extension decision was made within the board's authority and does not require shareholder approval, ensuring compliance with relevant regulations [2][9]. Risk Management - The company has established measures to manage risks associated with the loan, including close monitoring of Dongyue Environmental's financial status and ensuring that the loan does not adversely affect the company's normal operations [8][9]. Board and Supervisory Opinions - Both the board and supervisory committee support the loan extension, emphasizing its alignment with the company's development strategy and its potential to enhance overall capital efficiency [8][9].
南宁百货: 南宁百货大楼股份有限公司第九届董事会2025年第四次临时会议决议公告
Zheng Quan Zhi Xing· 2025-06-10 11:15
Core Points - The company held its fourth temporary board meeting of the ninth session on June 10, 2025, with all nine directors participating and voting [1] - The board approved the revision of the "14th Five-Year Plan" overall strategic plan with unanimous support [1] - The board also approved the establishment of a "Board Authorization Management System" with unanimous support [1] - The company agreed to sign a loan extension agreement with Nanning Pharmaceutical Co., Ltd., involving two loans totaling approximately 29.9 million yuan, with adjusted interest rates [1] Summary by Categories Strategic Planning - The board unanimously approved the revision of the "14th Five-Year Plan" overall strategic plan, which had previously been reviewed by the Strategic and Investment Committee [1] Governance - The board unanimously approved the establishment of a "Board Authorization Management System" to enhance management efficiency [1] Financial Agreements - The company will extend two loans to Nanning Pharmaceutical Co., Ltd., totaling approximately 29.9 million yuan, with the new interest rate adjusted from 1.81‰ to no more than 1.60‰, while other loan conditions remain unchanged [1]